Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alzheimer's disease: past, present, and future.

P J Whitehouse1

  • 1University Alzheimer Center, Cleveland, OH 44120-1013, USA. pjw3@po.cwru.edu

European Archives of Psychiatry and Clinical Neuroscience
|February 2, 2000
PubMed
Summary

Future dementia treatments require improved symptomatic therapies for Alzheimer's disease, focusing on cognitive and behavioral symptoms to enhance patient quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical issues in dementia.

Dialogues in clinical neuroscience·2011
Same author

The role of nutrients in the prevention and treatment of Alzheimer's disease: methodology for a systematic review.

European journal of neurology·2009
Same author

Speaking of research advance directives: planning for future research participation.

Neurology·2006
Same author

Twenty-four-hour rhythms of sleep-wake cycle and temperature in Alzheimer's disease.

The Journal of neuropsychiatry and clinical neurosciences·2004
Same author

Donepezil.

Drugs of today (Barcelona, Spain : 1998)·2004
Same author

Paying attention to acetylcholine: the key to wisdom and quality of life?

Progress in brain research·2003

Area of Science:

  • Neuroscience
  • Gerontology
  • Pharmacology

Background:

  • Dementia prevalence is increasing globally.
  • Alzheimer's disease (AD) poses significant challenges.
  • Past research laid groundwork for current therapeutic strategies.

Purpose of the Study:

  • To review progress in Alzheimer's disease treatment.
  • To highlight the importance of symptomatic relief.
  • To emphasize quality of life in AD interventions.

Main Methods:

  • Review of existing literature on AD medications.
  • Analysis of symptomatic treatment approaches.
  • Discussion of pathogenesis-based treatment development.

Main Results:

  • Cholinesterase inhibitors offer some symptomatic relief.
  • Novel neuroleptics show promise for behavioral symptoms.
  • Quality of life remains a key metric for treatment efficacy.

Conclusions:

  • Continued research is vital for advancing AD therapies.
  • Integrated approaches addressing cognitive and behavioral symptoms are needed.
  • Understanding pathogenesis is crucial for developing more effective treatments.

Related Experiment Videos